Previously, PAI-1 has been shown to be augmented in ARDS and particularly in COVID-19 [40], but notably, Cugno et al. did not find differences in PAI-1 concentration among patients with mild, moderate or severe disease [41]. This evidence concerns the gene SERPINE1 and COVID-19.